News
Latest NewsFDA NewsAdverse Event ManagementSupportive CareDisparities in Cancer CareDrug SafetyRadiation OncologySurvivorship Practice ManagementPreventionContributorsSponsored
Media
Expert ConnectionsMorning RoundsThe VitalsPodcastsVideosBetween the LinesFrom All AnglesMeeting of the MindsTraining Academy
Conferences
Conference CoverageConference Listing
Publications
More
CME/CE
Continuing Education
Resources
Case-Based Digest Rx Road MapEvents
Partners

Subscribe

  • News
  • Media
  • Conferences
  • Publications
  • CME/CE
  • Resources
  • Subscribe
  • Partners
  • Brain Cancer
  • Breast Cancer
    • Metastatic Breast Cancer
  • Gastrointestinal Cancer
    • Colorectal Cancer
    • Liver Cancer
    • Gastric Cancers
  • Genitourinary Cancer
    • Kidney Cancer
    • Bladder Cancer
    • Prostate Cancer
  • Gynecologic Cancers
    • Endometrial Cancer
    • Cervical Cancer
    • Ovarian Cancer
  • Head and Neck Cancers
  • Hematology
    • Leukemia
    • Graft-Vs-Host Disease
    • Myeloproliferative Neoplasms
    • Multiple Myeloma
    • Lymphoma
  • Lung Cancer
  • Pediatric Cancer
  • Sarcomas
  • Skin Cancer
    • Melanoma
Advertisement

Approaches to Bladder Cancer Treatment

EP. 1: Case Study: Recognizing the Typical Signs of Bladder Cancer

ByPetros Grivas, MD, PhD,Emily S. Weg, MD,Lisa Adams, PA-C,Nerina T. McDonald, PA-C
July 11th 2023

Expert panelists unpack a patient's bladder cancer presentation, evaluating the presence of typical signs and symptoms that could lead to a diagnosis.

EP. 2: Unlocking Bladder Cancer: A Guide to Effective Diagnosis and Staging

ByPetros Grivas, MD, PhD,Emily S. Weg, MD,Lisa Adams, PA-C,Nerina T. McDonald, PA-C
July 11th 2023

Experts share insights on standard work-up and staging practices for a patient with newly diagnosed bladder cancer.

Advertisement
Advertisement

Trending on Oncology Nursing News

1

Race Identified as Prognostic Indicator in Black Patients With AML

2

FDA Approves Liso-Cel in Pretreated R/R Marginal Zone Lymphoma

3

Odronextamab/CHOP Yields Early Efficacy in Untreated DLBCL

4

KRd Outperforms VRd in Newly Diagnosed Multiple Myeloma PFS

5

Families of Children With ALL Face Extreme Financial Toxicity

  • About Us
  • Editorial Board
  • Contact Us
  • CancerNetwork.com
  • CureToday.com
  • OncLive.com
  • TargetedOnc.com
  • Advertise
  • Privacy
  • Terms & Conditions
  • Do Not Sell My Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us